AEPGX
Price
$57.59
Change
+$0.07 (+0.12%)
Updated
May 8 closing price
Net Assets
128.01B
FIDZX
Price
$35.12
Change
+$0.04 (+0.11%)
Updated
May 8 closing price
Net Assets
9.84B
Ad is loading...

AEPGX vs FIDZX

Header iconAEPGX vs FIDZX Comparison
Open Charts AEPGX vs FIDZXBanner chart's image
American Funds Europacific Growth A
Price$57.59
Change+$0.07 (+0.12%)
VolumeN/A
Net Assets128.01B
Fidelity Advisor Intl Cap App Z
Price$35.12
Change+$0.04 (+0.11%)
VolumeN/A
Net Assets9.84B
AEPGX vs FIDZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPGX vs. FIDZX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a Buy and FIDZX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 128B vs. FIDZX (9.84B). AEPGX pays higher dividends than FIDZX: AEPGX (1.08) vs FIDZX (0.79). AEPGX was incepted earlier than FIDZX: AEPGX (41 years) vs FIDZX (8 years). AEPGX (0.85) is less costly to investors than FIDZX (0.75). FIDZX is a more actively managed with annual turnover of: 63.00 vs. AEPGX (30.00). FIDZX has a lower initial minimum investment than AEPGX: FIDZX (0) vs AEPGX (250). FIDZX annual gain was more profitable for investors over the last year : 11.85 vs. AEPGX (-0.70). FIDZX return over 5 years is better than : 63.12 vs. AEPGX (26.05).
AEPGXFIDZXAEPGX / FIDZX
Total Expense Ratio0.850.75113%
Annual Report Gross Expense Ratio0.850.75113%
Fund Existence41 years8 years-
Gain YTD7.2049.69474%
Front Load6%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets128B9.84B1,301%
Annual Yield % from dividends1.080.79138%
Returns for 1 year-0.7011.85-6%
Returns for 3 years20.7353.1839%
Returns for 5 years26.0563.1241%
Returns for 10 years17.06N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRVA25.071.75
+7.50%
Privia Health Group
REVB3.100.20
+6.92%
Revelation Biosciences Inc
TXO17.00N/A
N/A
TXO Partners LP
RAPT0.80N/A
-0.05%
RAPT Therapeutics
THC149.06-3.26
-2.14%
Tenet Healthcare Corp